Review fam72, glioblastoma multiforme (GBM) and beyond
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ho, Nguyen Thi Thanh | - |
dc.contributor.author | Rahane, Chinmay Satish | - |
dc.contributor.author | Pramanik, Subrata | - |
dc.contributor.author | Kim, Pok-Son | - |
dc.contributor.author | Kutzner, Arne | - |
dc.contributor.author | Heese, Klaus | - |
dc.date.accessioned | 2022-07-07T00:34:12Z | - |
dc.date.available | 2022-07-07T00:34:12Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 2072-6694 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/142257 | - |
dc.description.abstract | Neural stem cells (NSCs) offer great potential for regenerative medicine due to their excellent ability to differentiate into various specialized cell types of the brain. In the central nervous system (CNS), NSC renewal and differentiation are under strict control by the regulation of the pivotal SLIT?ROBO Rho GTPase activating protein 2 (SRGAP2)?Family with sequence similarity to the 72 (FAM72) master gene (i.e., |?SRGAP2?FAM72?|) via a divergent gene transcription activation mechanism. If the gene transcription control unit (i.e., the intergenic region of the two sub?gene units, SRGAP2 and FAM72) gets out of control, NSCs may transform into cancer stem cells and generate brain tumor cells responsible for brain cancer such as glioblastoma multiforme (GBM). Here, we discuss the surveillance of this |?SRGAP2?FAM72?| master gene and its role in GBM, and also in light of FAM72 for diagnosing various types of cancers outside of the CNS. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI AG | - |
dc.title | Review fam72, glioblastoma multiforme (GBM) and beyond | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Heese, Klaus | - |
dc.identifier.doi | 10.3390/cancers13051025 | - |
dc.identifier.scopusid | 2-s2.0-85101724494 | - |
dc.identifier.wosid | 000627996400001 | - |
dc.identifier.bibliographicCitation | Cancers, v.13, no.5, pp.1 - 28 | - |
dc.relation.isPartOf | Cancers | - |
dc.citation.title | Cancers | - |
dc.citation.volume | 13 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 28 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | CELL-CYCLE TRANSCRIPTION | - |
dc.subject.keywordPlus | LONG NONCODING RNAS | - |
dc.subject.keywordPlus | DNA-METHYLATION | - |
dc.subject.keywordPlus | GROWTH-FACTOR | - |
dc.subject.keywordPlus | ANTISENSE OLIGONUCLEOTIDE | - |
dc.subject.keywordPlus | MOLECULAR-MECHANISMS | - |
dc.subject.keywordPlus | GENOMIC CHARACTERIZATION | - |
dc.subject.keywordPlus | SIGNALING PATHWAYS | - |
dc.subject.keywordPlus | NEURONAL MIGRATION | - |
dc.subject.keywordPlus | CHEMICAL TOXICITY | - |
dc.subject.keywordAuthor | Brain cancer | - |
dc.subject.keywordAuthor | Cell cycle | - |
dc.subject.keywordAuthor | Differentiation | - |
dc.subject.keywordAuthor | Glioblastoma | - |
dc.subject.keywordAuthor | Proliferation | - |
dc.subject.keywordAuthor | RAS | - |
dc.subject.keywordAuthor | SRGAP2 | - |
dc.subject.keywordAuthor | Stem cell | - |
dc.subject.keywordAuthor | TP53 | - |
dc.identifier.url | https://www.mdpi.com/2072-6694/13/5/1025 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.